MORBIFIX-CV-325
MRP: 1,680
Packaging: 10x6
Pack Type: capsule
Composition:
Cefixime 200mg + Clavulanic Acid 125mg
Indication:
Febrile LRTIs - Surgical Prophylaxis - URTIs - UTIs - Otitis Media - Dental Infections
Description:
This combination contains:
Cefixime 200mg – a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis.
Clavulanic Acid 125mg – a beta-lactamase inhibitor that prevents bacterial resistance by inhibiting enzymes that degrade cefixime.
Together, they offer enhanced action against beta-lactamase producing bacteria, making this formulation effective even against resistant bacterial strains.
Tags:
- Effective against drug-resistant bacteria
- Treats a broad spectrum of infections
- Better protection against beta-lactamase-producing organisms
- Improved clinical success in complex infections
- Convenient oral tablet form
Usage Information
Dosage
Adults: One tablet twice daily (every 12 hours) Children: Not recommended in this strength – pediatric doses should be prescribed separately Route: Oral Duration: 5–14 days or as directed by a healthcare professional Note: Best taken after meals
Side Effects
Common: Diarrhea Nausea Abdominal pain Rash Less Common but Serious: Hypersensitivity reactions Clostridium difficile-associated diarrhea Liver enzyme elevation
Contraindications
Do NOT use if: Known allergy to cephalosporins or penicillins History of severe gastrointestinal diseases (like colitis) Severe renal impairment without dose adjustment Concurrent use of live bacterial vaccines
Availability
Cefixime 200mg with Clavulanic Acid Cefixime Clavulanate Tablet uses Broad-spectrum antibiotic Antibiotic for resistant infection Cefixime combination tablet Cephalosporin with beta-lactamase inhibitor